Opinion: Toward inclusive global governance of human genome editing

Hanzhi Yu¹, Lan Xue², Rodolphe Barrangou³, Shaowei Chen⁴, Ying Huang^{5

6

7}

Affiliations

¹ School of Public Affairs, Zhejiang University, Hangzhou 310058, China.
² School of Public Policy and Management, Tsinghua University, Beijing 100084, China.
³ Department of Food, Bioprocessing, and Nutrition Sciences, North Carolina State University, Raleigh, NC 27606.
⁴ School of Public Administration, Hunan University, Changsha 410082, China; schen@hnu.edu.cn ying.huang@whu.edu.cn.
⁵ Center for Studies of Information Resources, Center for Science, Technology, & Education Assessment (CSTEA), School of Information Management, Wuhan University, Wuhan 430072, China; schen@hnu.edu.cn ying.huang@whu.edu.cn.
⁶ Centre for R&D Monitoring (ECOOM), KU Leuven, Leuven 3000, Belgium.
⁷ Department of Management, Strategy and Innovation (MSI), KU Leuven, Leuven 3000, Belgium.

Hanzhi Yu et al. Proc Natl Acad Sci U S A. 2021.

. 2021 Nov 23;118(47):e2118540118.

doi: 10.1073/pnas.2118540118.

Hanzhi Yu¹, Lan Xue², Rodolphe Barrangou³, Shaowei Chen⁴, Ying Huang^{5

6

7}

¹ School of Public Affairs, Zhejiang University, Hangzhou 310058, China.
² School of Public Policy and Management, Tsinghua University, Beijing 100084, China.
³ Department of Food, Bioprocessing, and Nutrition Sciences, North Carolina State University, Raleigh, NC 27606.
⁴ School of Public Administration, Hunan University, Changsha 410082, China; schen@hnu.edu.cn ying.huang@whu.edu.cn.
⁵ Center for Studies of Information Resources, Center for Science, Technology, & Education Assessment (CSTEA), School of Information Management, Wuhan University, Wuhan 430072, China; schen@hnu.edu.cn ying.huang@whu.edu.cn.
⁶ Centre for R&D Monitoring (ECOOM), KU Leuven, Leuven 3000, Belgium.
⁷ Department of Management, Strategy and Innovation (MSI), KU Leuven, Leuven 3000, Belgium.

No abstract available

Figures

1. Brokowski C., Opinion: Do CRISPR germline ethics statements cut it? CRISPR J. 1, 115–125 (2018). - PMC - PubMed
1. Berg P., Baltimore D., Brenner S., Roblin R. O., Singer M. F., Opinion: Summary statement of the Asilomar conference on recombinant DNA molecules. Proc. Natl. Acad. Sci. U.S.A. 72, 1981–1984 (1975). - PMC - PubMed
1. Gregorowius D., Biller-Andorno N., Deplazes-Zemp A., Opinion: The role of scientific self-regulation for the control of genome editing in the human germline: The lessons from the Asilomar and the Napa meetings show how self-regulation and public deliberation can lead to regulation of new biotechnologies. EMBO Rep. 18, 355–358 (2017). - PMC - PubMed
1. Fredrickson D. S., “Asilomar and recombinant DNA: The end of the beginning” in Biomedical Politics, Hanna K. E., Ed. (The National Academies Press, Washington, DC, 1991), pp. 258–298.
1. European Group on Ethics in Science and New Technologies, Opinion on the Ethics of Genome Editing (Publications Office of the European Union, Luxembourg, 2021).